{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:26:52Z","timestamp":1792686412700,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.diabres.2021.108847","type":"journal-article","created":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T04:40:59Z","timestamp":1619844059000},"page":"108847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Associated autoimmunity in Type 1 Diabetes and latent autoimmune diabetes of adults: The role of glutamic-acid decarboxylase autoantibodies"],"prefix":"10.1016","volume":"175","author":[{"given":"Dimitrios","family":"Gougourelas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampos","family":"Tsentidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina Maria","family":"Koufadaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Koutsovasilis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eupraxia","family":"Gougourela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyridon","family":"Karanasios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexios","family":"Sotiropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Bousboulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriaki Athina","family":"Karavanaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2021.108847_b0005","doi-asserted-by":"crossref","unstructured":"Standards of Medical Care in Diabetes\u20142014. 2014;37:S14-S80 DOI: 10.2337\/dc14-S014 %J Diabetes Care.","DOI":"10.2337\/dc14-S014"},{"key":"10.1016\/j.diabres.2021.108847_b0010","doi-asserted-by":"crossref","unstructured":"Diagnosis and Classification of Diabetes Mellitus. 2009;32:S62-S7 DOI: 10.2337\/dc09-S062 %J Diabetes Care.","DOI":"10.2337\/dc09-S062"},{"key":"10.1016\/j.diabres.2021.108847_b0015","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/S0140-6736(16)30507-4","article-title":"Environmental risk factors for type 1 diabetes","volume":"387","author":"Rewers","year":"2016","journal-title":"Lancet (London, England)."},{"key":"10.1016\/j.diabres.2021.108847_b0020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/dc15-1111","article-title":"A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults","volume":"39","author":"Oram","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2021.108847_b0025","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S2213-8587(17)30362-5","article-title":"Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank","volume":"6","author":"Thomas","year":"2018","journal-title":"The lancet Diabetes & endocrinology."},{"key":"10.1016\/j.diabres.2021.108847_b0030","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrendo.2017.99","article-title":"Adult-onset autoimmune diabetes: current knowledge and implications for management","volume":"13","author":"Buzzetti","year":"2017","journal-title":"Nature reviews Endocrinology."},{"key":"10.1016\/j.diabres.2021.108847_b0035","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3390\/genes10090710","article-title":"HLA-DQB1 and HLA-DRB1 Variants Confer Susceptibility to Latent Autoimmune Diabetes in Adults: Relative Predispositional Effects among Allele Groups","volume":"10","author":"Zhang","year":"2019","journal-title":"Genes (Basel)."},{"key":"10.1016\/j.diabres.2021.108847_b0040","article-title":"Etiology and Pathogenesis of Latent Autoimmune Diabetes in Adults (LADA) Compared to Type 2 Diabetes","author":"Carlsson","year":"201910320","journal-title":"Front Physiol."},{"key":"10.1016\/j.diabres.2021.108847_b0045","article-title":"Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes","author":"Mishra","year":"20171588","journal-title":"BMC Med."},{"key":"10.1016\/j.diabres.2021.108847_b0050","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1464-5491.2010.02997.x","article-title":"Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5)","volume":"27","author":"Zampetti","year":"2010","journal-title":"Diabet Med."},{"key":"10.1016\/j.diabres.2021.108847_b0055","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.autrev.2012.02.001","article-title":"Updated assessment of the prevalence, spectrum and case definition of autoimmune disease","volume":"11","author":"Hayter","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.diabres.2021.108847_b0060","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.autrev.2015.05.002","article-title":"Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus (T1DM)","volume":"14","author":"Kakleas","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.diabres.2021.108847_b0065","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1210\/jc.2016-2478","article-title":"Autoimmune Diseases in Children and Adults With Type 1 Diabetes From the T1D Exchange Clinic Registry","volume":"101","author":"Hughes","year":"2016","journal-title":"The Journal of Clinical Endocrinology & Metabolism."},{"key":"10.1016\/j.diabres.2021.108847_b0070","doi-asserted-by":"crossref","unstructured":"Hughes JW, Bao YK, Salam M, Joshi P, Kilpatrick CR, Juneja K, et al. Late-Onset T1DM and Older Age Predict Risk of Additional Autoimmune Disease. 2019;42:32-8 DOI: 10.2337\/dc18-1157 %J Diabetes Care.","DOI":"10.2337\/dc18-1157"},{"key":"10.1016\/j.diabres.2021.108847_b0075","doi-asserted-by":"crossref","unstructured":"Kozhakhmetova A, Wyatt RC, Caygill C, Williams C, Long AE, Chandler K, et al. A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study. 2018;192:251-8 DOI: 10.1111\/cei.13115.","DOI":"10.1111\/cei.13115"},{"key":"10.1016\/j.diabres.2021.108847_b0080","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/1753-0407.12856","article-title":"High prevalence of comorbid autoimmune diseases in adults with type 1 diabetes from the HealthFacts database","volume":"11","author":"Bao","year":"2018","journal-title":"J Diabetes"},{"key":"10.1016\/j.diabres.2021.108847_b0085","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1464-5491.2004.01162.x","article-title":"Clustering of autoimmune disease in parents of siblings from the Type 1 diabetes Warren repository","volume":"21","author":"Tait","year":"2004","journal-title":"Diabet Med."},{"issue":"Suppl 2","key":"10.1016\/j.diabres.2021.108847_b0090","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.2337\/dcs15-2003","article-title":"Shared Genetic Basis for Type 1 Diabetes, Islet Autoantibodies, and Autoantibodies Associated With Other Immune-Mediated Diseases in Families With Type 1 Diabetes","volume":"38","author":"Brorsson","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2021.108847_b0095","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.autrev.2011.10.004","article-title":"Are autoimmune diseases predictable?","volume":"11","author":"Tob\u00f3n","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.diabres.2021.108847_b0100","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.humimm.2019.02.012","article-title":"Prevalence of autoimmune diseases and clinical significance of autoantibody profile: Data from National Institute of Hygiene in Rabat","volume":"80","author":"Missoum","year":"2019","journal-title":"Morocco. Human immunology."},{"key":"10.1016\/j.diabres.2021.108847_b0105","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1007\/s00125-005-1960-7","article-title":"Latent autoimmune diabetes in adults (LADA) should be less latent","volume":"48","author":"Fourlanos","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2021.108847_b0110","first-page":"4062","article-title":"High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 (insulin-dependent) diabetic patients","volume":"84","author":"De Block","year":"1999","journal-title":"The Belgian Diabetes Registry. The Journal of clinical endocrinology and metabolism."},{"key":"10.1016\/j.diabres.2021.108847_b0115","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2337\/dc10-1756","article-title":"Additional autoimmune disease found in 33% of patients at type 1 diabetes onset","volume":"34","author":"Triolo","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2021.108847_b0120","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00592-012-0395-0","article-title":"Type 1 diabetes and celiac disease in adults: glycemic control and diabetic complications","volume":"50","author":"Bakker","year":"2013","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.diabres.2021.108847_b0125","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.dld.2008.03.013","article-title":"Undetected coeliac disease in the elderly: a biopsy-proven population-based study","volume":"40","author":"Vilppula","year":"2008","journal-title":"Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver."},{"key":"10.1016\/j.diabres.2021.108847_b0130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2249.2003.02205.x","article-title":"Gliadin, endomysial and thyroid antibodies in patients with latent autoimmune diabetes of adults (LADA)","volume":"133","author":"Kucera","year":"2003","journal-title":"Clin Exp Immunol."},{"key":"10.1016\/j.diabres.2021.108847_b0135","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.1464-5491.2000.00354.x","article-title":"Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and the HLA DQA1*0501-DQB1*0301 haplotype in Type 1 diabetes mellitus","volume":"17","author":"De Block","year":"2000","journal-title":"Belgian Diabetes Registry. Diabet Med."},{"key":"10.1016\/j.diabres.2021.108847_b0140","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1365-2249.2001.01668.x","article-title":"Beta-cell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA-DQ types in type 1 diabetes","volume":"126","author":"De Block","year":"2001","journal-title":"Clin Exp Immunol."},{"key":"10.1016\/j.diabres.2021.108847_b0145","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1210\/jc.2009-1308","article-title":"Homozygosity of the polymorphism MICA5.1 identifies extreme risk of progression to overt adrenal insufficiency among 21-hydroxylase antibody-positive patients with type 1 diabetes","volume":"94","author":"Triolo","year":"2009","journal-title":"The Journal of clinical endocrinology and metabolism."},{"key":"10.1016\/j.diabres.2021.108847_b0150","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2337\/diacare.28.4.850","article-title":"Autoantibody \u201csubspecificity\u201d in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups","volume":"28","author":"Barker","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2021.108847_b0155","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1530\/EJE-14-0342","article-title":"High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7)","volume":"171","author":"Zampetti","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.diabres.2021.108847_b0160","doi-asserted-by":"crossref","unstructured":"Radtke MA, Midthjell K, Nilsen TIL, Grill V. Heterogeneity of Patients With Latent Autoimmune Diabetes in Adults: Linkage to Autoimmunity Is Apparent Only in Those With Perceived Need for Insulin Treatment. Results from the Nord-Tr\u00f8ndelag Health (HUNT) study. 2009;32:245-50 DOI: 10.2337\/dc08-1468 %J Diabetes Care.","DOI":"10.2337\/dc08-1468"},{"key":"10.1016\/j.diabres.2021.108847_b0165","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000336923","article-title":"Gastric autoimmunity in children and adolescents with type 1 diabetes: a prospective study","volume":"77","author":"Kakleas","year":"2012","journal-title":"Hormone research in paediatrics."},{"key":"10.1016\/j.diabres.2021.108847_b0170","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/BF00257339","article-title":"Coincident presence of thyro-gastric autoimmunity at onset of type 1 (insulin-dependent) diabetes","volume":"24","author":"Riley","year":"1983","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2021.108847_b0175","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1007\/s00125-012-2463-y","article-title":"Time dynamics of autoantibodies are coupled to phenotypes and add to the heterogeneity of autoimmune diabetes in adults: the HUNT study","volume":"55","author":"S\u00f8rgjerd","year":"2012","journal-title":"Norway. Diabetologia."},{"key":"10.1016\/j.diabres.2021.108847_b0180","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2337\/dc12-0931","article-title":"Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7","volume":"36","author":"Hawa","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2021.108847_b0185","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s00125-017-4308-1","article-title":"Early prediction of autoimmune (type 1) diabetes","volume":"60","author":"Regnell","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2021.108847_b0190","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2337\/dc16-0181","article-title":"Reversion of \u03b2-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study","volume":"39","author":"Vehik","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2021.108847_b0195","first-page":"201","article-title":"Screening for associated autoimmunity in children and adolescents with type 1 diabetes mellitus (T1DM)","volume":"71","author":"Karavanaki","year":"2009","journal-title":"Horm Res"},{"key":"10.1016\/j.diabres.2021.108847_b0200","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1007\/s00125-007-0745-6","article-title":"GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77","volume":"50","author":"Desai","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2021.108847_b0205","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2337\/db09-0923","article-title":"Genetic heterogeneity in latent autoimmune diabetes is linked to various degrees of autoimmune activity: results from the Nord-Tr\u00f8ndelag Health Study","volume":"59","author":"Pettersen","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2021.108847_b0210","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(97)03062-6","article-title":"UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes","volume":"350","author":"Turner","year":"1997","journal-title":"UK Prospective Diabetes Study Group. Lancet (London, England)"},{"key":"10.1016\/j.diabres.2021.108847_b0215","doi-asserted-by":"crossref","first-page":"279","DOI":"10.33549\/physiolres.930485","article-title":"Anti-GAD-positive patients with type 1 diabetes mellitus have higher prevalence of autoimmune thyroiditis than anti-GAD-negative patients with type 1 and type 2 diabetes mellitus","volume":"53","author":"B\u00e1rov\u00e1","year":"2004","journal-title":"Physiol Res"},{"key":"10.1016\/j.diabres.2021.108847_b0220","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1210\/jc.2012-2037","article-title":"GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6)","volume":"97","author":"Zampetti","year":"2012","journal-title":"The Journal of clinical endocrinology and metabolism."},{"key":"10.1016\/j.diabres.2021.108847_b0225","first-page":"853","volume":"21","author":"Talal","year":"1978","journal-title":"Autoimmunity and the immunologic network."},{"key":"10.1016\/j.diabres.2021.108847_b0230","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2217\/epi-2016-0143","article-title":"Age-associated DNA methylation changes in naive CD4(+) T cells suggest an evolving autoimmune epigenotype in aging T cells","volume":"9","author":"Dozmorov","year":"2017","journal-title":"Epigenomics."},{"key":"10.1016\/j.diabres.2021.108847_b0235","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1741-7015-11-94","article-title":"Age-related autoimmunity","volume":"11","author":"Vadasz","year":"2013","journal-title":"BMC Med."}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721002060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721002060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:17:47Z","timestamp":1759173467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822721002060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":47,"alternative-id":["S0168822721002060"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108847","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associated autoimmunity in Type 1 Diabetes and latent autoimmune diabetes of adults: The role of glutamic-acid decarboxylase autoantibodies","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108847"}}